Click for best price
Eosinophilic Disease Market Size, Share 2024
The global Eosinophilic Disease market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Corticosteroids Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Eosinophilic Disease include Takeda Pharmaceutical Company Limited, Ellodi Pharmaceuticals, Bristol-Myers Squibb Company, AstraZeneca, GSK plc, Regeneron Pharmaceuticals Inc, Allakos Inc, Arena Pharmaceuticals Ltd and Revolo Biotherapeutics, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Eosinophils are the variety of white infection, allergy blood cells and one of the major immune system components helps in combating various and inflammatory diseases. Eosinophils develops and mature in the bone marrow and represent upto 6% of bone marrow. If the threshold of 1500?cells/?l crosses called as eosinophil-driven diseases, which causes severe inflammatory diseases and organ damage.
This report aims to provide a comprehensive presentation of the global market for Eosinophilic Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eosinophilic Disease. This report contains market size and forecasts of Eosinophilic Disease in global, including the following market information:
- Global Eosinophilic Disease Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Eosinophilic Disease Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Eosinophilic Disease companies in 2023 (%)
We surveyed the Eosinophilic Disease manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eosinophilic Disease Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Eosinophilic Disease Market Segment Percentages, by Type, 2023 (%)
- Corticosteroids
- Monoclonal Antibodies
- Anti-cytokine Drug
- Cytotoxic Drug
Global Eosinophilic Disease Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Eosinophilic Disease Market Segment Percentages, by Application, 2023 (%)
- Eosinophilic Esophagitis
- Eosinophilic Granulomatosis with Polyangiitis
- Hyper-eosinophilic Syndrome
- Nasal Polyposis
- Other
Global Eosinophilic Disease Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Eosinophilic Disease Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Eosinophilic Disease revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Eosinophilic Disease revenues share in global market, 2023 (%)
- Key companies Eosinophilic Disease sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Eosinophilic Disease sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Takeda Pharmaceutical Company Limited
- Ellodi Pharmaceuticals
- Bristol-Myers Squibb Company
- AstraZeneca
- GSK plc
- Regeneron Pharmaceuticals Inc
- Allakos Inc
- Arena Pharmaceuticals Ltd
- Revolo Biotherapeutics
- DBV Technologies
- Cipla Inc
- Sun Pharmaceutical Industries Ltd
- Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Eosinophilic Disease, market overview.
Chapter 2: Global Eosinophilic Disease market size in revenue and volume.
Chapter 3: Detailed analysis of Eosinophilic Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Eosinophilic Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Eosinophilic Disease capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Eosinophilic Disease Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Eosinophilic Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Eosinophilic Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Eosinophilic Disease Overall Market Size
2.1 Global Eosinophilic Disease Market Size: 2023 VS 2030
2.2 Global Eosinophilic Disease Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Eosinophilic Disease Sales: 2019-2030
3 Company Landscape
3.1 Top Eosinophilic Disease Players in Global Market
3.2 Top Global Eosinophilic Disease Companies Ranked by Revenue
3.3 Global Eosinophilic Disease Revenue by Companies
3.4 Global Eosinophilic Disease Sales by Companies
3.5 Global Eosinophilic Disease Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Eosinophilic Disease Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Eosinophilic Disease Product Type
3.8 Tier 1, Tier 2 and Tier 3 Eosinophilic Disease Players in Global Market
3.8.1 List of Global Tier 1 Eosinophilic Disease Companies
3.8.2 List of Global Tier 2 and Tier 3 Eosinophilic Disease Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Eosinophilic Disease Market Size Markets, 2023 & 2030
4.1.2 Corticosteroids
4.1.3 Monoclonal Antibodies
4.1.4 Anti-cytokine Drug
4.1.5 Cytotoxic Drug
4.2 By Type - Global Eosinophilic Disease Revenue & Forecasts
4.2.1 By Type - Global Eosinophilic Disease Revenue, 2019-2024
4.2.2 By Type - Global Eosinophilic Disease Revenue, 2025-2030
4.2.3 By Type - Global Eosinophilic Disease Revenue Market Share, 2019-2030
4.3 By Type - Global Eosinophilic Disease Sales & Forecasts
4.3.1 By Type - Global Eosinophilic Disease Sales, 2019-2024
4.3.2 By Type - Global Eosinophilic Disease Sales, 2025-2030
4.3.3 By Type - Global Eosinophilic Disease Sales Market Share, 2019-2030
4.4 By Type - Global Eosinophilic Disease Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Eosinophilic Disease Market Size, 2023 & 2030
5.1.2 Eosinophilic Esophagitis
5.1.3 Eosinophilic Granulomatosis with Polyangiitis
5.1.4 Hyper-eosinophilic Syndrome
5.1.5 Nasal Polyposis
5.1.6 Other
5.2 By Application - Global Eosinophilic Disease Revenue & Forecasts
5.2.1 By Application - Global Eosinophilic Disease Revenue, 2019-2024
5.2.2 By Application - Global Eosinophilic Disease Revenue, 2025-2030
5.2.3 By Application - Global Eosinophilic Disease Revenue Market Share, 2019-2030
5.3 By Application - Global Eosinophilic Disease Sales & Forecasts
5.3.1 By Application - Global Eosinophilic Disease Sales, 2019-2024
5.3.2 By Application - Global Eosinophilic Disease Sales, 2025-2030
5.3.3 By Application - Global Eosinophilic Disease Sales Market Share, 2019-2030
5.4 By Application - Global Eosinophilic Disease Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Eosinophilic Disease Market Size, 2023 & 2030
6.2 By Region - Global Eosinophilic Disease Revenue & Forecasts
6.2.1 By Region - Global Eosinophilic Disease Revenue, 2019-2024
6.2.2 By Region - Global Eosinophilic Disease Revenue, 2025-2030
6.2.3 By Region - Global Eosinophilic Disease Revenue Market Share, 2019-2030
6.3 By Region - Global Eosinophilic Disease Sales & Forecasts
6.3.1 By Region - Global Eosinophilic Disease Sales, 2019-2024
6.3.2 By Region - Global Eosinophilic Disease Sales, 2025-2030
6.3.3 By Region - Global Eosinophilic Disease Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Eosinophilic Disease Revenue, 2019-2030
6.4.2 By Country - North America Eosinophilic Disease Sales, 2019-2030
6.4.3 US Eosinophilic Disease Market Size, 2019-2030
6.4.4 Canada Eosinophilic Disease Market Size, 2019-2030
6.4.5 Mexico Eosinophilic Disease Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Eosinophilic Disease Revenue, 2019-2030
6.5.2 By Country - Europe Eosinophilic Disease Sales, 2019-2030
6.5.3 Germany Eosinophilic Disease Market Size, 2019-2030
6.5.4 France Eosinophilic Disease Market Size, 2019-2030
6.5.5 U.K. Eosinophilic Disease Market Size, 2019-2030
6.5.6 Italy Eosinophilic Disease Market Size, 2019-2030
6.5.7 Russia Eosinophilic Disease Market Size, 2019-2030
6.5.8 Nordic Countries Eosinophilic Disease Market Size, 2019-2030
6.5.9 Benelux Eosinophilic Disease Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Eosinophilic Disease Revenue, 2019-2030
6.6.2 By Region - Asia Eosinophilic Disease Sales, 2019-2030
6.6.3 China Eosinophilic Disease Market Size, 2019-2030
6.6.4 Japan Eosinophilic Disease Market Size, 2019-2030
6.6.5 South Korea Eosinophilic Disease Market Size, 2019-2030
6.6.6 Southeast Asia Eosinophilic Disease Market Size, 2019-2030
6.6.7 India Eosinophilic Disease Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Eosinophilic Disease Revenue, 2019-2030
6.7.2 By Country - South America Eosinophilic Disease Sales, 2019-2030
6.7.3 Brazil Eosinophilic Disease Market Size, 2019-2030
6.7.4 Argentina Eosinophilic Disease Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Eosinophilic Disease Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Eosinophilic Disease Sales, 2019-2030
6.8.3 Turkey Eosinophilic Disease Market Size, 2019-2030
6.8.4 Israel Eosinophilic Disease Market Size, 2019-2030
6.8.5 Saudi Arabia Eosinophilic Disease Market Size, 2019-2030
6.8.6 UAE Eosinophilic Disease Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Takeda Pharmaceutical Company Limited
7.1.1 Takeda Pharmaceutical Company Limited Company Summary
7.1.2 Takeda Pharmaceutical Company Limited Business Overview
7.1.3 Takeda Pharmaceutical Company Limited Eosinophilic Disease Major Product Offerings
7.1.4 Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.1.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.2 Ellodi Pharmaceuticals
7.2.1 Ellodi Pharmaceuticals Company Summary
7.2.2 Ellodi Pharmaceuticals Business Overview
7.2.3 Ellodi Pharmaceuticals Eosinophilic Disease Major Product Offerings
7.2.4 Ellodi Pharmaceuticals Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.2.5 Ellodi Pharmaceuticals Key News & Latest Developments
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Company Summary
7.3.2 Bristol-Myers Squibb Company Business Overview
7.3.3 Bristol-Myers Squibb Company Eosinophilic Disease Major Product Offerings
7.3.4 Bristol-Myers Squibb Company Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.3.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Eosinophilic Disease Major Product Offerings
7.4.4 AstraZeneca Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 GSK plc
7.5.1 GSK plc Company Summary
7.5.2 GSK plc Business Overview
7.5.3 GSK plc Eosinophilic Disease Major Product Offerings
7.5.4 GSK plc Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.5.5 GSK plc Key News & Latest Developments
7.6 Regeneron Pharmaceuticals Inc
7.6.1 Regeneron Pharmaceuticals Inc Company Summary
7.6.2 Regeneron Pharmaceuticals Inc Business Overview
7.6.3 Regeneron Pharmaceuticals Inc Eosinophilic Disease Major Product Offerings
7.6.4 Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.6.5 Regeneron Pharmaceuticals Inc Key News & Latest Developments
7.7 Allakos Inc
7.7.1 Allakos Inc Company Summary
7.7.2 Allakos Inc Business Overview
7.7.3 Allakos Inc Eosinophilic Disease Major Product Offerings
7.7.4 Allakos Inc Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.7.5 Allakos Inc Key News & Latest Developments
7.8 Arena Pharmaceuticals Ltd
7.8.1 Arena Pharmaceuticals Ltd Company Summary
7.8.2 Arena Pharmaceuticals Ltd Business Overview
7.8.3 Arena Pharmaceuticals Ltd Eosinophilic Disease Major Product Offerings
7.8.4 Arena Pharmaceuticals Ltd Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.8.5 Arena Pharmaceuticals Ltd Key News & Latest Developments
7.9 Revolo Biotherapeutics
7.9.1 Revolo Biotherapeutics Company Summary
7.9.2 Revolo Biotherapeutics Business Overview
7.9.3 Revolo Biotherapeutics Eosinophilic Disease Major Product Offerings
7.9.4 Revolo Biotherapeutics Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.9.5 Revolo Biotherapeutics Key News & Latest Developments
7.10 DBV Technologies
7.10.1 DBV Technologies Company Summary
7.10.2 DBV Technologies Business Overview
7.10.3 DBV Technologies Eosinophilic Disease Major Product Offerings
7.10.4 DBV Technologies Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.10.5 DBV Technologies Key News & Latest Developments
7.11 Cipla Inc
7.11.1 Cipla Inc Company Summary
7.11.2 Cipla Inc Eosinophilic Disease Business Overview
7.11.3 Cipla Inc Eosinophilic Disease Major Product Offerings
7.11.4 Cipla Inc Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.11.5 Cipla Inc Key News & Latest Developments
7.12 Sun Pharmaceutical Industries Ltd
7.12.1 Sun Pharmaceutical Industries Ltd Company Summary
7.12.2 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Business Overview
7.12.3 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Major Product Offerings
7.12.4 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.12.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.13 Sanofi
7.13.1 Sanofi Company Summary
7.13.2 Sanofi Eosinophilic Disease Business Overview
7.13.3 Sanofi Eosinophilic Disease Major Product Offerings
7.13.4 Sanofi Eosinophilic Disease Sales and Revenue in Global (2019-2024)
7.13.5 Sanofi Key News & Latest Developments
8 Global Eosinophilic Disease Production Capacity, Analysis
8.1 Global Eosinophilic Disease Production Capacity, 2019-2030
8.2 Eosinophilic Disease Production Capacity of Key Manufacturers in Global Market
8.3 Global Eosinophilic Disease Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Eosinophilic Disease Supply Chain Analysis
10.1 Eosinophilic Disease Industry Value Chain
10.2 Eosinophilic Disease Upstream Market
10.3 Eosinophilic Disease Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Eosinophilic Disease Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Eosinophilic Disease in Global Market
Table 2. Top Eosinophilic Disease Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Eosinophilic Disease Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Eosinophilic Disease Revenue Share by Companies, 2019-2024
Table 5. Global Eosinophilic Disease Sales by Companies, (K Units), 2019-2024
Table 6. Global Eosinophilic Disease Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Eosinophilic Disease Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Eosinophilic Disease Product Type
Table 9. List of Global Tier 1 Eosinophilic Disease Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Eosinophilic Disease Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Eosinophilic Disease Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Eosinophilic Disease Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Eosinophilic Disease Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Eosinophilic Disease Sales (K Units), 2019-2024
Table 15. By Type - Global Eosinophilic Disease Sales (K Units), 2025-2030
Table 16. By Application ? Global Eosinophilic Disease Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Eosinophilic Disease Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Eosinophilic Disease Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Eosinophilic Disease Sales (K Units), 2019-2024
Table 20. By Application - Global Eosinophilic Disease Sales (K Units), 2025-2030
Table 21. By Region ? Global Eosinophilic Disease Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Eosinophilic Disease Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Eosinophilic Disease Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Eosinophilic Disease Sales (K Units), 2019-2024
Table 25. By Region - Global Eosinophilic Disease Sales (K Units), 2025-2030
Table 26. By Country - North America Eosinophilic Disease Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Eosinophilic Disease Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Eosinophilic Disease Sales, (K Units), 2019-2024
Table 29. By Country - North America Eosinophilic Disease Sales, (K Units), 2025-2030
Table 30. By Country - Europe Eosinophilic Disease Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Eosinophilic Disease Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Eosinophilic Disease Sales, (K Units), 2019-2024
Table 33. By Country - Europe Eosinophilic Disease Sales, (K Units), 2025-2030
Table 34. By Region - Asia Eosinophilic Disease Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Eosinophilic Disease Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Eosinophilic Disease Sales, (K Units), 2019-2024
Table 37. By Region - Asia Eosinophilic Disease Sales, (K Units), 2025-2030
Table 38. By Country - South America Eosinophilic Disease Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Eosinophilic Disease Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Eosinophilic Disease Sales, (K Units), 2019-2024
Table 41. By Country - South America Eosinophilic Disease Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Eosinophilic Disease Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Eosinophilic Disease Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Eosinophilic Disease Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Eosinophilic Disease Sales, (K Units), 2025-2030
Table 46. Takeda Pharmaceutical Company Limited Company Summary
Table 47. Takeda Pharmaceutical Company Limited Eosinophilic Disease Product Offerings
Table 48. Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Takeda Pharmaceutical Company Limited Key News & Latest Developments
Table 50. Ellodi Pharmaceuticals Company Summary
Table 51. Ellodi Pharmaceuticals Eosinophilic Disease Product Offerings
Table 52. Ellodi Pharmaceuticals Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Ellodi Pharmaceuticals Key News & Latest Developments
Table 54. Bristol-Myers Squibb Company Company Summary
Table 55. Bristol-Myers Squibb Company Eosinophilic Disease Product Offerings
Table 56. Bristol-Myers Squibb Company Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Bristol-Myers Squibb Company Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Eosinophilic Disease Product Offerings
Table 60. AstraZeneca Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. GSK plc Company Summary
Table 63. GSK plc Eosinophilic Disease Product Offerings
Table 64. GSK plc Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. GSK plc Key News & Latest Developments
Table 66. Regeneron Pharmaceuticals Inc Company Summary
Table 67. Regeneron Pharmaceuticals Inc Eosinophilic Disease Product Offerings
Table 68. Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Regeneron Pharmaceuticals Inc Key News & Latest Developments
Table 70. Allakos Inc Company Summary
Table 71. Allakos Inc Eosinophilic Disease Product Offerings
Table 72. Allakos Inc Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Allakos Inc Key News & Latest Developments
Table 74. Arena Pharmaceuticals Ltd Company Summary
Table 75. Arena Pharmaceuticals Ltd Eosinophilic Disease Product Offerings
Table 76. Arena Pharmaceuticals Ltd Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Arena Pharmaceuticals Ltd Key News & Latest Developments
Table 78. Revolo Biotherapeutics Company Summary
Table 79. Revolo Biotherapeutics Eosinophilic Disease Product Offerings
Table 80. Revolo Biotherapeutics Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Revolo Biotherapeutics Key News & Latest Developments
Table 82. DBV Technologies Company Summary
Table 83. DBV Technologies Eosinophilic Disease Product Offerings
Table 84. DBV Technologies Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. DBV Technologies Key News & Latest Developments
Table 86. Cipla Inc Company Summary
Table 87. Cipla Inc Eosinophilic Disease Product Offerings
Table 88. Cipla Inc Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Cipla Inc Key News & Latest Developments
Table 90. Sun Pharmaceutical Industries Ltd Company Summary
Table 91. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Product Offerings
Table 92. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 94. Sanofi Company Summary
Table 95. Sanofi Eosinophilic Disease Product Offerings
Table 96. Sanofi Eosinophilic Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Sanofi Key News & Latest Developments
Table 98. Eosinophilic Disease Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 99. Global Eosinophilic Disease Capacity Market Share of Key Manufacturers, 2021-2024
Table 100. Global Eosinophilic Disease Production by Region, 2019-2024 (K Units)
Table 101. Global Eosinophilic Disease Production by Region, 2025-2030 (K Units)
Table 102. Eosinophilic Disease Market Opportunities & Trends in Global Market
Table 103. Eosinophilic Disease Market Drivers in Global Market
Table 104. Eosinophilic Disease Market Restraints in Global Market
Table 105. Eosinophilic Disease Raw Materials
Table 106. Eosinophilic Disease Raw Materials Suppliers in Global Market
Table 107. Typical Eosinophilic Disease Downstream
Table 108. Eosinophilic Disease Downstream Clients in Global Market
Table 109. Eosinophilic Disease Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Eosinophilic Disease Segment by Type in 2023
Figure 2. Eosinophilic Disease Segment by Application in 2023
Figure 3. Global Eosinophilic Disease Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Eosinophilic Disease Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Eosinophilic Disease Revenue, 2019-2030 (US$, Mn)
Figure 7. Eosinophilic Disease Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Eosinophilic Disease Revenue in 2023
Figure 9. By Type - Global Eosinophilic Disease Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Eosinophilic Disease Revenue Market Share, 2019-2030
Figure 11. By Type - Global Eosinophilic Disease Sales Market Share, 2019-2030
Figure 12. By Type - Global Eosinophilic Disease Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Eosinophilic Disease Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Eosinophilic Disease Revenue Market Share, 2019-2030
Figure 15. By Application - Global Eosinophilic Disease Sales Market Share, 2019-2030
Figure 16. By Application - Global Eosinophilic Disease Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Eosinophilic Disease Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Eosinophilic Disease Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Eosinophilic Disease Revenue Market Share, 2019-2030
Figure 20. By Region - Global Eosinophilic Disease Sales Market Share, 2019-2030
Figure 21. By Country - North America Eosinophilic Disease Revenue Market Share, 2019-2030
Figure 22. By Country - North America Eosinophilic Disease Sales Market Share, 2019-2030
Figure 23. US Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Eosinophilic Disease Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Eosinophilic Disease Sales Market Share, 2019-2030
Figure 28. Germany Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 29. France Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Eosinophilic Disease Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Eosinophilic Disease Sales Market Share, 2019-2030
Figure 37. China Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 41. India Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Eosinophilic Disease Revenue Market Share, 2019-2030
Figure 43. By Country - South America Eosinophilic Disease Sales Market Share, 2019-2030
Figure 44. Brazil Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Eosinophilic Disease Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Eosinophilic Disease Sales Market Share, 2019-2030
Figure 48. Turkey Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Eosinophilic Disease Revenue, (US$, Mn), 2019-2030
Figure 52. Global Eosinophilic Disease Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Eosinophilic Disease by Region, 2023 VS 2030
Figure 54. Eosinophilic Disease Industry Value Chain
Figure 55. Marketing Channels
